The trial against DePuy involving 8 New York plaintiffs injured by DePuy Pinnacle hip implants has been postponed. The trial was set to occur today on September 5th, 2017 before U.S. District Judge Ed Kinkeade in the Northern District of Texas. Judge Kinkeade currently presides over 9,300 cases alleging DePuy’s Pinnacle hip implants are defective.… Read More
December 1st, 2016: A Texas jury returned a verdict of $1.04 billion against Johnson & Johnson DePuy Orthopaedics. This bellwether trial was the second bellwether verdict against Johnson and Johnson, which was previously found liable for $498 million for 5 separate DePuy Pinnacle plaintiffs. The $1.04 billion cover six plaintiffs whose cases were tried in… Read More
The Federal Drug Administration (FDA) has labeled Pelvic Organ Prolapse (POP) devices as “high risk”, after thousands of injuries had been reported. The FDA noted more than 4,000 reports of adverse events or complications associated with transvaginal surgical mesh for POP or Stress Urinary Incontinence (SUI) repair from 2005 to 2010. The FDA previously classified POP… Read More
Earlier this year, a group of private companies and institutions released a new mobile application in collaboration with the Food and Drug Administration Center for Devices and Radiologic Health. It is called MedWatcher, and is a mobile app for use on tablets and smartphones to make reporting negative effects of drugs, medical devices, and vaccines… Read More
On July 10, 2012, Stryker Orthopaedics recalled its Rejuvenate hip system and ABG II modular-neck stems, both of which are popular components of many of its most popular hip implant systems. Both the Rejuvenate and ABG II modular-neck stems may be used with either metal or ceramic hip implants. However, the Stryker components themselves are… Read More
